T1	Outcomes 2325 2365	with a projected median overall survival
T2	Outcomes 2377 2384	months.
T3	Outcomes 2385 2410	Marrow and blood (T cell)
T4	Outcomes 2560 2603	had a median of 100% donor (T cell)-derived
T5	Outcomes 2609 2650	There has been no secondary graft failure
T6	Outcomes 2677 2702	patient died of pneumonia
T7	Outcomes 2708 2718	1 of liver
T8	Outcomes 2767 2847	Bu as pretransplant conditioning is safe in high-risk myeloid leukemia patients;
T9	Outcomes 2852 2897	clofarabine is sufficiently immunosuppressive
T10	Outcomes 3049 3083	evaluate the antileukemic efficacy
T11	Outcomes 3106 3107	.
T12	Outcomes 3108 3162	Bu as pretransplant conditioning therapy are warranted
